The European Union is negotiating with Pfizer and BioNTech on a deal that could double their supply of Covid-19 vaccine as countries race to immunise enough people to tame a fresh virus resurgence. The attempt to secure more of the Pfizer/BioNTech vaccine comes less than a week after the 27-member bloc boosted its original 200-million-dose order to 300 million under a previous option arrangement. The EU passed up an opportunity to secure greater numbers of the Pfizer/BioNTech vaccine last summer, according to an internal EU document seen by Reuters. However, the EU has locked up less of that shot, with a contract for as many as 160 million doses. Additional supplies“We are in talks about whether and how we can provide further vaccine doses from Europe, for Europe this year,” BioNTech chief executive Ugur Sahin said in an emailed statement.

Source: The Irish Times January 05, 2021 15:06 UTC